# NEPHROLITHIASIS

## Types of stones and risk factors (_Nat Rev_ 2016;2:16008)

• **Calcium** (Ca oxalate > Ca phosphate): **70–90% of kidney stones** (_NEJM_ 2010;363:954)

Urine findings: ↑ Ca, ↑ oxalate (Ca-ox only), ↑ pH (Ca-phos only), ↓ citrate, ↓ volume

2° hypercalciuria: 1° hyperparathyroidism, distal RTA, sarcoid, Li use

2° hyperoxaluria: Crohn’s, ileal disease with intact colon, gastric bypass, pancreatic insuffic.

Diet: ↑ animal protein, ↑ sucrose, ↑ Na, ↓ K, ↓ fluid, ↓ fruits/vegetables, ↑ vit. C, ↓ Ca

• **Uric acid:** 5–10% of kidney stones, radiolucent on plain film

Urine findings: ↑ uric acid, ↓ pH (eg, from chronic diarrhea)

• **Magnesium ammonium phosphate** (“struvite” or “triple phosphate”)

Chronic upper UTI with urea-splitting organisms (eg, _Proteus, Klebs_) → ↑ urine NH3, pH >7

• **Cystine:** inherited defects of tubular amino acid reabsorption

## 臨床表現

• Hematuria (absence does not exclude diagnosis), flank pain, N/V, dysuria, frequency

• Ureteral obstruction (stones >5 mm unlikely to pass spont.) → AKI if solitary kidney

• UTI: ↑ risk of infection proximal to stone; urinalysis of distal urine may be normal

## Workup (_Urology_ 2014;84:533)

• **Non-contrast CT** 97% Se, 96% Sp (ureteral dilation without stone suggests recent passage); U/S (Se 57%, Sp 98%) may serve as initial test in stable patient (_NEJM_ 2014;371:1100)

• Strain urine for stone to analyze; U/A & UCx; electrolytes, BUN/Cr, Ca, PO4, PTH

• 24-h urine × 2 (>6 wk after acute setting) for Ca, PO4, oxalate, citrate, Na, Cr, pH, K, vol.

## Acute 治療 (_CJASN_ 2016;11:1305)

• Analgesia (narcotics ± NSAIDs; combination superior, _Ann Emerg Med_ 2006;48:173), ensure adequate fluid repletion, antibiotics if UTI

• α-blocker > CCB to pass stone if ≤10 mm (Cochrane;2014:CD008509, _Lancet_ 2006;368:1171)

• Indications for **immediate urologic eval and**/**or hosp:** obstruction (esp. solitary or transplant kidney), urosepsis, intractable pain or vomiting, significant AKI

• Urologic Rx: lithotripsy (_NEJM_ 2012:367:50), ureteroscopic removal, lap/perc nephrolithotomy

## Chronic 治療 (_CJASN_ 2016;11:1305 & 2017;12:1699)

• Increase fluid intake (>2 L/d) for goal UOP 2 L/d (_J Nephrol_ 2016;29:211)

• Calcium stones: 24-h urine identifies **specific urinary risk factors to treat**

Diet: ↓ Na and meat (_NEJM_ 2002;346:77), ↓ oxalate foods & sucrose/fructose

Meds: thiazides (↓ urine Ca), K-citrate if low urine citrate, allopurinol if high urine uric acid

Avoid low dietary Ca as ↑ oxalate absorp (_NEJM_ 2002;346:77), unclear role of Ca suppl.

• Uric acid: fluid intake, urine alkalinization (K-citrate) to pH 6.5–7, allopurinol

• Magnesium ammonium phosphate (struvite): antibiotics for UTI; urologic intervention; acetohydroxamic acid; urease inhibitor reserved for experienced clinician, poorly tolerated

• Cystine: fluid, urine alkaliniz (K-citrate) to 7–8, D\-penicillamine, tiopronin (_KI_ 2006;69:1041)
